These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34997910)
1. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors. Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Allicock M J Cancer Surviv; 2023 Aug; 17(4):1149-1160. PubMed ID: 34997910 [TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017. Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577 [TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and patterns of prescription medication use among cancer survivors. Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083 [TBL] [Abstract][Full Text] [Related]
4. Substance use, substance use disorders, and treatment in adolescent and young adult cancer survivors-Results from a national survey. Ji X; Cummings JR; Mertens AC; Wen H; Effinger KE Cancer; 2021 Sep; 127(17):3223-3231. PubMed ID: 33974717 [TBL] [Abstract][Full Text] [Related]
5. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study. Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894 [TBL] [Abstract][Full Text] [Related]
6. Impacts of the Early COVID-19 Pandemic Among a National Sample of Adolescent and Young Adult Cancer Survivors in the United States. Betts AC; Shay LA; Allicock M; Preston SM; Grimes A; Murphy CC J Adolesc Young Adult Oncol; 2023 Jun; 12(3):324-330. PubMed ID: 36173754 [No Abstract] [Full Text] [Related]
7. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014. Hsu CD; Nichols HB; Lund JL J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998 [TBL] [Abstract][Full Text] [Related]
8. Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer. Ewig CLY; Cheng YM; Li HS; Wong JCL; Cho AHY; Poon FMH; Li CK; Cheung YT Front Oncol; 2021; 11():642544. PubMed ID: 33869032 [TBL] [Abstract][Full Text] [Related]
9. Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis. Vyas A; Alghaith G; Hufstader-Gabriel M Qual Life Res; 2020 Aug; 29(8):2029-2037. PubMed ID: 32207028 [TBL] [Abstract][Full Text] [Related]
10. Short- and long-term impact of cancer on employment and financial outcomes of adolescents and young adults (AYAs): a large population-based case-control registry study in the Netherlands. Janssen SHM; van der Meer DJ; van Eenbergen MCHJ; Manten-Horst E; van der Graaf WTA; Husson O ESMO Open; 2022 Aug; 7(4):100521. PubMed ID: 35772237 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults. Pauly NJ; Brown JD J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965 [TBL] [Abstract][Full Text] [Related]
12. National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States. Jairam V; Yang DX; Verma V; Yu JB; Park HS JAMA Netw Open; 2020 Aug; 3(8):e2013605. PubMed ID: 32804217 [TBL] [Abstract][Full Text] [Related]
13. Association between polypharmacy and health-related quality of life among cancer survivors in the United States. Babcock ZR; Kogut SJ; Vyas A J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in adolescents and young adults with and without cancer, using propensity score matching. Choi E; Becker H; Jung H J Cancer Surviv; 2023 Apr; 17(2):279-289. PubMed ID: 34850323 [TBL] [Abstract][Full Text] [Related]
15. Early Posttherapy Opioid Prescription, Potential Misuse, and Substance Use Disorder Among Pediatric Cancer Survivors. Ji X; Hu X; Brock KE; Mertens AC; Cummings JR; Effinger KE J Natl Cancer Inst; 2022 Jun; 114(6):895-906. PubMed ID: 35262708 [TBL] [Abstract][Full Text] [Related]
16. Additional medical costs of chronic conditions among adolescent and young adult cancer survivors. Abdelhadi OA; Joseph J; Pollock BH; Keegan THM J Cancer Surviv; 2022 Jun; 16(3):487-496. PubMed ID: 33899161 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH. Moore HN; Mao L; Oramasionwu CU AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408 [TBL] [Abstract][Full Text] [Related]
18. Trends in personal and family member opioid prescriptions prior to a diagnosis of an opioid-related problem among adolescents and young adults. Cohrs AC; Pacula RL; Dick AW; Stein BD; Druss BG; Leslie DL Subst Abus; 2021; 42(4):483-486. PubMed ID: 33797321 [No Abstract] [Full Text] [Related]
19. Connecting with healthcare providers at diagnosis: adolescent/young adult cancer survivors' perspectives. Phillips CR; Haase JE; Broome ME; Carpenter JS; Frankel RM Int J Qual Stud Health Well-being; 2017 Dec; 12(1):1325699. PubMed ID: 28617094 [TBL] [Abstract][Full Text] [Related]
20. Psychological distress and associated additional medical expenditures in adolescent and young adult cancer survivors. Abdelhadi OA; Pollock BH; Joseph JG; Keegan THM Cancer; 2022 Apr; 128(7):1523-1531. PubMed ID: 35001391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]